{
    "clinical_study": {
        "@rank": "21650", 
        "acronym": "CAMFIB", 
        "arm_group": [
            {
                "arm_group_label": "indocyanine green fluorescent cholangiography", 
                "arm_group_type": "Experimental", 
                "description": "use of indocyanine green fluorescent cholangiography in the patients of this arm, an indocyanine green fluorescent cholangiography is performed"
            }, 
            {
                "arm_group_label": "methylene blue", 
                "arm_group_type": "Active Comparator", 
                "description": "injection of methylene blue during the surgery"
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of the present study is to evaluate whether the use of indocyanine green fluorescent\n      cholangiography is responsible in a decrease of biliary fistula's rate in patients with\n      liver diseases requiring liver resection."
        }, 
        "brief_title": "Use of Indocyanine Green Cholangiography and Methylene Blue to Detect Postoperative Biliary Fistula After Hepatectomy", 
        "completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Liver Disease", 
        "condition_browse": {
            "mesh_term": [
                "Biliary Fistula", 
                "Fistula", 
                "Liver Diseases"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  benin or malignant liver disease with resection of 2 or more segments\n\n          -  liver resection by laparotomy\n\n          -  written consent\n\n        Exclusion Criteria:\n\n          -  previous hepatectomy\n\n          -  emergency surgery\n\n          -  allergy to indocyanine green\n\n          -  allergy to methylene blue\n\n          -  pregnancy or breastfeeding"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "132", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 30, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01847612", 
            "org_study_id": "PI 2013-843-0003", 
            "secondary_id": "2013-000408-40"
        }, 
        "intervention": [
            {
                "arm_group_label": "indocyanine green fluorescent cholangiography", 
                "intervention_name": "indocyanine green fluorescent cholangiography", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "methylene blue", 
                "intervention_name": "methylene blue", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Methylene Blue"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "per operative cholangiography", 
            "liver resection", 
            "biliary fistula"
        ], 
        "lastchanged_date": "November 26, 2013", 
        "location": {
            "contact": {
                "email": "regimbeau.jean-marc@chu-amiens.fr", 
                "last_name": "jean marc regimbeau, MD, PhD", 
                "phone": "+33 3 22 66 83 00"
            }, 
            "facility": {
                "address": {
                    "city": "Amiens", 
                    "country": "France"
                }, 
                "name": "Amiens University Hospital"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "2", 
        "official_title": "Evaluation of Indocyanine Green Fluorescent Cholangiography Versus Methylene Blue to Detect Postoperative Biliary Fistula After Hepatectomy: Randomized Controlled Study", 
        "overall_contact": {
            "email": "regimbeau.jean-marc@chu-amiens.fr", 
            "last_name": "jean marc regimbeau, MD, phD", 
            "phone": "+33 3 22 66 83 00"
        }, 
        "overall_official": {
            "affiliation": "CHU amiens", 
            "last_name": "jean marc regimbeau, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "France: Committee for the Protection of Personnes", 
                "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "the biliary fistula is defined as a bilirubin in the drain three times higher than the serum bilirubin.\nthe primary endpoint will be evaluated by a medical committee composed by investigators not involved in the patients enrollment.", 
            "measure": "biliary fistula rate", 
            "safety_issue": "Yes", 
            "time_frame": "postoperative week 4"
        }, 
        "reference": {
            "PMID": "23533786", 
            "citation": "Nguyen-Khac E, Lobry C, Chatelain D, Fuks D, Joly JP, Brevet M, Tramier B, Mouly C, Hautefeuille V, Chauffert B, Regimbeau JM. A Reappraisal of Chemotherapy-Induced Liver Injury in Colorectal Liver Metastases before the Era of Antiangiogenics. Int J Hepatol. 2013;2013:314868. doi: 10.1155/2013/314868. Epub 2013 Mar 7."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01847612"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Centre Hospitalier Universitaire, Amiens", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Centre Hospitalier Universitaire, Amiens", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}